On Invalid Date, Molecular Partners Ag (NASDAQ: MOLN) reported Q2 2024 earnings per share (EPS) of -$0.51, up 6.07% year over year. Total Molecular Partners Ag earnings for the quarter were -$16.76 million. In the same quarter last year, Molecular Partners Ag's earnings per share (EPS) was -$0.54.
As of Q3 2024, Molecular Partners Ag's earnings has grown year over year. Molecular Partners Ag's earnings in the past year totalled -$68.60 million.
What was MOLN's revenue last quarter?
On Invalid Date, Molecular Partners Ag (NASDAQ: MOLN) reported Q2 2024 revenue of $1.72 million up 273.73% year over year. In the same quarter last year, Molecular Partners Ag's revenue was $461.11 thousand.
What was MOLN's revenue growth in the past year?
As of Q3 2024, Molecular Partners Ag's revenue has grown -7.78% year over year. This is 81.56 percentage points lower than the US Biotechnology industry revenue growth rate of 73.78%. Molecular Partners Ag's revenue in the past year totalled $9.36 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.